blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3060189

EP3060189 - IMMERSION DEVICE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  15.03.2019
Database last updated on 25.09.2024
FormerThe patent has been granted
Status updated on  06.04.2018
FormerGrant of patent is intended
Status updated on  07.12.2017
FormerExamination is in progress
Status updated on  25.08.2017
Most recent event   Tooltip10.07.2020Lapse of the patent in a contracting state
New state(s): IS
published on 12.08.2020  [2020/33]
Applicant(s)For all designated states
BSN medical GmbH
Quickbornstrasse 24
20253 Hamburg / DE
[2017/11]
Former [2016/35]For all designated states
BSN Medical GmbH
Quickbornstrasse 24
20253 Hamburg / DE
Inventor(s)01 / SUSCHEK, Christoph, V
Flurstrasse 20
40764 Langenfeld / DE
 [2016/35]
Representative(s)FARAGO Patentanwälte GmbH
Thierschstraße 11
80538 München / DE
[N/P]
Former [2016/35]Jostarndt Patentanwalts-AG
Philipsstrasse 8
52068 Aachen / DE
Application number, filing date14795974.624.10.2014
[2016/35]
WO2014EP72844
Priority number, dateDE2013101752424.10.2013         Original published format: DE102013017524
[2016/35]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report
No.:WO2015059273
Date:30.04.2015
Language:DE
[2015/17]
Type: A1 Application with search report 
No.:EP3060189
Date:31.08.2016
Language:DE
The application published by WIPO in one of the EPO official languages on 30.04.2015 takes the place of the publication of the European patent application.
[2016/35]
Type: B1 Patent specification 
No.:EP3060189
Date:09.05.2018
Language:DE
[2018/19]
Search report(s)International search report - published on:EP30.04.2015
ClassificationIPC:A61H35/00
[2016/35]
CPC:
A61H33/14 (EP,US); A61H35/00 (EP,US); A61H35/006 (EP,US);
A61K9/0009 (EP,US); A61M35/30 (EP,US); A61P17/00 (EP);
A61P17/02 (EP); A61P17/04 (EP); A61P25/00 (EP);
A61P25/02 (EP); A61P25/04 (EP); A61P29/00 (EP);
A61P3/00 (EP); A61P3/10 (EP); A61P31/04 (EP);
A61P31/10 (EP); A61P33/00 (EP); A61P37/00 (EP);
A61P37/06 (EP); A61P9/00 (EP); A61P9/12 (EP);
A61H2033/048 (EP,US); A61H2230/255 (EP,US); A61H2230/505 (EP,US);
A61M2202/0275 (US); A61M2205/12 (US); A61M2205/36 (US);
A61M2210/08 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/35]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:EINTAUCHVORRICHTUNG[2016/35]
English:IMMERSION DEVICE[2016/35]
French:DISPOSITIF D'IMMERSION[2016/35]
Entry into regional phase24.05.2016National basic fee paid 
24.05.2016Designation fee(s) paid 
24.05.2016Examination fee paid 
Examination procedure24.08.2015Request for preliminary examination filed
International Preliminary Examining Authority: EP
12.05.2016Amendment by applicant (claims and/or description)
24.05.2016Examination requested  [2016/35]
28.08.2017Despatch of a communication from the examining division (Time limit: M02)
27.10.2017Reply to a communication from the examining division
08.12.2017Communication of intention to grant the patent
27.03.2018Fee for grant paid
27.03.2018Fee for publishing/printing paid
27.03.2018Receipt of the translation of the claim(s)
Opposition(s)12.02.2019No opposition filed within time limit [2019/16]
Fees paidRenewal fee
31.10.2016Renewal fee patent year 03
02.11.2017Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU24.10.2014
AL09.05.2018
CY09.05.2018
CZ09.05.2018
DK09.05.2018
EE09.05.2018
ES09.05.2018
FI09.05.2018
HR09.05.2018
IT09.05.2018
LT09.05.2018
LV09.05.2018
MC09.05.2018
MK09.05.2018
MT09.05.2018
PL09.05.2018
PT09.05.2018
RO09.05.2018
RS09.05.2018
SI09.05.2018
SK09.05.2018
SM09.05.2018
TR09.05.2018
BG09.08.2018
NO09.08.2018
GR10.08.2018
IS09.09.2018
IE24.10.2018
LU24.10.2018
BE31.10.2018
CH31.10.2018
LI31.10.2018
[2020/32]
Former [2020/31]HU24.10.2014
AL09.05.2018
CY09.05.2018
CZ09.05.2018
DK09.05.2018
EE09.05.2018
ES09.05.2018
FI09.05.2018
HR09.05.2018
IT09.05.2018
LT09.05.2018
LV09.05.2018
MC09.05.2018
MK09.05.2018
MT09.05.2018
PL09.05.2018
PT09.05.2018
RO09.05.2018
RS09.05.2018
SI09.05.2018
SK09.05.2018
SM09.05.2018
TR09.05.2018
BG09.08.2018
NO09.08.2018
GR10.08.2018
IE24.10.2018
LU24.10.2018
BE31.10.2018
CH31.10.2018
LI31.10.2018
Former [2020/28]AL09.05.2018
CZ09.05.2018
DK09.05.2018
EE09.05.2018
ES09.05.2018
FI09.05.2018
HR09.05.2018
IT09.05.2018
LT09.05.2018
LV09.05.2018
MC09.05.2018
MT09.05.2018
PL09.05.2018
PT09.05.2018
RO09.05.2018
RS09.05.2018
SI09.05.2018
SK09.05.2018
SM09.05.2018
TR09.05.2018
BG09.08.2018
NO09.08.2018
GR10.08.2018
IE24.10.2018
LU24.10.2018
BE31.10.2018
CH31.10.2018
LI31.10.2018
Former [2020/16]AL09.05.2018
CZ09.05.2018
DK09.05.2018
EE09.05.2018
ES09.05.2018
FI09.05.2018
HR09.05.2018
IT09.05.2018
LT09.05.2018
LV09.05.2018
MC09.05.2018
MT09.05.2018
PL09.05.2018
RO09.05.2018
RS09.05.2018
SI09.05.2018
SK09.05.2018
SM09.05.2018
TR09.05.2018
BG09.08.2018
NO09.08.2018
GR10.08.2018
IE24.10.2018
LU24.10.2018
BE31.10.2018
CH31.10.2018
LI31.10.2018
Former [2020/08]AL09.05.2018
CZ09.05.2018
DK09.05.2018
EE09.05.2018
ES09.05.2018
FI09.05.2018
HR09.05.2018
IT09.05.2018
LT09.05.2018
LV09.05.2018
MC09.05.2018
MT09.05.2018
PL09.05.2018
RO09.05.2018
RS09.05.2018
SI09.05.2018
SK09.05.2018
SM09.05.2018
BG09.08.2018
NO09.08.2018
GR10.08.2018
IE24.10.2018
LU24.10.2018
BE31.10.2018
CH31.10.2018
LI31.10.2018
Former [2019/51]AL09.05.2018
CZ09.05.2018
DK09.05.2018
EE09.05.2018
ES09.05.2018
FI09.05.2018
HR09.05.2018
IT09.05.2018
LT09.05.2018
LV09.05.2018
MC09.05.2018
PL09.05.2018
RO09.05.2018
RS09.05.2018
SI09.05.2018
SK09.05.2018
SM09.05.2018
BG09.08.2018
NO09.08.2018
GR10.08.2018
IE24.10.2018
LU24.10.2018
BE31.10.2018
CH31.10.2018
LI31.10.2018
Former [2019/48]CZ09.05.2018
DK09.05.2018
EE09.05.2018
ES09.05.2018
FI09.05.2018
HR09.05.2018
IT09.05.2018
LT09.05.2018
LV09.05.2018
MC09.05.2018
PL09.05.2018
RO09.05.2018
RS09.05.2018
SI09.05.2018
SK09.05.2018
SM09.05.2018
BG09.08.2018
NO09.08.2018
GR10.08.2018
IE24.10.2018
LU24.10.2018
BE31.10.2018
CH31.10.2018
LI31.10.2018
Former [2019/40]CZ09.05.2018
DK09.05.2018
EE09.05.2018
ES09.05.2018
FI09.05.2018
HR09.05.2018
IT09.05.2018
LT09.05.2018
LV09.05.2018
MC09.05.2018
PL09.05.2018
RO09.05.2018
RS09.05.2018
SI09.05.2018
SK09.05.2018
SM09.05.2018
BG09.08.2018
NO09.08.2018
GR10.08.2018
LU24.10.2018
BE31.10.2018
CH31.10.2018
LI31.10.2018
Former [2019/38]CZ09.05.2018
DK09.05.2018
EE09.05.2018
ES09.05.2018
FI09.05.2018
HR09.05.2018
IT09.05.2018
LT09.05.2018
LV09.05.2018
MC09.05.2018
PL09.05.2018
RO09.05.2018
RS09.05.2018
SI09.05.2018
SK09.05.2018
SM09.05.2018
BG09.08.2018
NO09.08.2018
GR10.08.2018
LU24.10.2018
BE31.10.2018
Former [2019/30]CZ09.05.2018
DK09.05.2018
EE09.05.2018
ES09.05.2018
FI09.05.2018
HR09.05.2018
IT09.05.2018
LT09.05.2018
LV09.05.2018
MC09.05.2018
PL09.05.2018
RO09.05.2018
RS09.05.2018
SI09.05.2018
SK09.05.2018
SM09.05.2018
BG09.08.2018
NO09.08.2018
GR10.08.2018
LU24.10.2018
Former [2019/28]CZ09.05.2018
DK09.05.2018
EE09.05.2018
ES09.05.2018
FI09.05.2018
HR09.05.2018
IT09.05.2018
LT09.05.2018
LV09.05.2018
MC09.05.2018
PL09.05.2018
RO09.05.2018
RS09.05.2018
SI09.05.2018
SK09.05.2018
SM09.05.2018
BG09.08.2018
NO09.08.2018
GR10.08.2018
Former [2019/26]CZ09.05.2018
DK09.05.2018
EE09.05.2018
ES09.05.2018
FI09.05.2018
HR09.05.2018
IT09.05.2018
LT09.05.2018
LV09.05.2018
PL09.05.2018
RO09.05.2018
RS09.05.2018
SI09.05.2018
SK09.05.2018
SM09.05.2018
BG09.08.2018
NO09.08.2018
GR10.08.2018
Former [2019/11]CZ09.05.2018
DK09.05.2018
EE09.05.2018
ES09.05.2018
FI09.05.2018
HR09.05.2018
IT09.05.2018
LT09.05.2018
LV09.05.2018
PL09.05.2018
RO09.05.2018
RS09.05.2018
SK09.05.2018
SM09.05.2018
BG09.08.2018
NO09.08.2018
GR10.08.2018
Former [2019/10]CZ09.05.2018
DK09.05.2018
EE09.05.2018
ES09.05.2018
FI09.05.2018
HR09.05.2018
LT09.05.2018
LV09.05.2018
PL09.05.2018
RO09.05.2018
RS09.05.2018
SK09.05.2018
BG09.08.2018
NO09.08.2018
GR10.08.2018
Former [2019/09]DK09.05.2018
EE09.05.2018
ES09.05.2018
FI09.05.2018
HR09.05.2018
LT09.05.2018
LV09.05.2018
RS09.05.2018
BG09.08.2018
NO09.08.2018
GR10.08.2018
Former [2019/08]DK09.05.2018
ES09.05.2018
FI09.05.2018
HR09.05.2018
LT09.05.2018
LV09.05.2018
RS09.05.2018
BG09.08.2018
NO09.08.2018
GR10.08.2018
Former [2018/52]ES09.05.2018
FI09.05.2018
HR09.05.2018
LT09.05.2018
LV09.05.2018
RS09.05.2018
BG09.08.2018
NO09.08.2018
GR10.08.2018
Former [2018/51]ES09.05.2018
FI09.05.2018
HR09.05.2018
LT09.05.2018
LV09.05.2018
RS09.05.2018
BG09.08.2018
NO09.08.2018
Former [2018/50]ES09.05.2018
FI09.05.2018
HR09.05.2018
LT09.05.2018
BG09.08.2018
NO09.08.2018
Former [2018/47]ES09.05.2018
FI09.05.2018
LT09.05.2018
NO09.08.2018
Cited inInternational search[X]WO02074223  (AHN SHIN YOUNG [KR], et al) [X] 45-52,60,61 * the whole document *;
 [X]WO03003989  (CERAMATEC INC [US]) [X] 45-52,60,61 * page 3, line 12; figure 1 *;
 [X]US2013096490  (PELKUS ADRIAN [US]) [X] 45-52,60,61 * abstract ** figures 1, 3B *;
 [X]  - OPLANDER C ET AL, "A new method for sustained generation of ultra-pure nitric oxide-containing gas mixtures via controlled UVA-photolysis of nitrite solutions", NITRIC OXIDE: BIOLOGY AND CHEMISTRY, ACADEMIC PRESS, AMSTERDAM, NL, vol. 23, no. 4, doi:10.1016/J.NIOX.2010.08.001, ISSN 1089-8603, (20101215), pages 275 - 283, (20100814), XP027430288 [X] 45-52,60,61 * abstract *

DOI:   http://dx.doi.org/10.1016/j.niox.2010.08.001
by applicantUS5396882
 WO9507610
 WO9746853
 DE19823748
 US2003039697
 US6673338
 US7105502
 US7122529
 EP1903003
 US2013224083
    - K.D. KRÖNCKE; K. FEHSEL; V. KOLB-BACHOFEN, "Inducible nitric oxide synthase in human diseases", CLIN EXP IMMUNOL, (1998), vol. 113, pages 147 - 56
    - K. MATSUNAGA; R.F. FURCHGOTT, "Responses of rabbit aorta to nitric oxide and superoxide generated by ultraviolet irradiation of solutions containing inorganic nitrite", J PHARMACOL EXP THER, (1991), vol. 259, pages 1140 - 6
    - M. FISCHER; P. WARNECK, "Photodecomposition of nitrite and undissociated nitrous acid in aqueous solution", J.PHYS.CHEM., (1996), vol. 100, pages 18749 - 18756
    - H. STREHLOW; I. WAGNER, "Flash photolysis in aqueous nitrite solutions", Z. PHYS. CHEM. NF, (1982), vol. 132, pages 151 - 160
    - S. FRANK; H. KAMPFER; C. WETZLER; J. PFEILSCHIFTER, "Nitric oxide drives skin repair: novel functions of an established mediator", KIDNEY INT, (2002), vol. 61, doi:doi:10.1046/j.1523-1755.2002.00237.x, pages 882 - 8, XP009093154

DOI:   http://dx.doi.org/10.1046/j.1523-1755.2002.00237.x
    - S. FRANK; B. STALLMEYER; H. KAMPFER; N. KOLB; J. PFEILSCHIFTER, "Nitric oxide triggers enhanced induction of vascular endothelial growth factor expression in cultured keratinocytes (HaCaT) and during cutaneous wound repair", FASEB J, (1999), vol. 13, pages 2002 - 14
    - S. FRANK; H. KAMPFER; M. PODDA; R. KAUFMANN; J. PFEILSCHIFTER, "Identification of copper/zinc superoxide dismutase as a nitric oxide- regulated gene in human (HaCaT) keratinocytes: implications for keratinocyte proliferation", BIOCHEM J, (2000), vol. 346, pages 719 - 28
    - K. YAMASAKI; H.D. EDINGTON; C. MCCLOSKY; E. TZENG; A. LIZONOVA; I. KOVESDI; D.L. STEED; T.R. BILLIAR, "Reversal of impaired wound repair in iNOS-deficient mice by topical adenoviral-mediated iNOS gene transfer", J CLIN INVEST, (1998), vol. 101, pages 967 - 71
    - J. PFEILSCHIFTER; W. EBERHARDT; A. HUWILER, "Nitric oxide and mechanisms of redox signalling: matrix and matrix-metabolizing enzymes as prime nitric oxide targets", EUR J PHARMACOL, (2001), vol. 429, pages 279 - 86
    - Y. ISHII; T. OGURA; M. TATEMICHI; H. FUJISAWA; F. OTSUKA; H. ESUMI, "Induction of matrix metalloproteinase gene transcription by nitric oxide and mechanisms of MMP-1 gene induction in human melanoma cell lines", INT J CANCER, (2003), vol. 103, pages 161 - 8
    - M.B. WITTE; F.J. THORNTON; D.T. EFRON; A. BARBUL, "Enhancement of fibroblast collagen synthesis by nitric oxide.", NITRIC OXIDE, (2000), vol. 4, pages 572 - 82
    - F. VERRECCHIA; A. MAUVIEL, "TGF-beta and TNF-alpha: antagonistic cytokines controlling type 1 collagen gene expression", CELL SIGNAL, (2004), vol. 16, doi:doi:10.1016/j.cellsig.2004.02.007, pages 873 - 80, XP055155955

DOI:   http://dx.doi.org/10.1016/j.cellsig.2004.02.007
    - D.A. SIWIK; W.S. COLUCCI, "Regulation of matrix metalloproteinases by cytokines and reactive oxygen/nitrogen species in the myocardium", HEART FAIL REV, (2004), vol. 9, doi:doi:10.1023/B:HREV.0000011393.40674.13, pages 43 - 51, XP019207286

DOI:   http://dx.doi.org/10.1023/B:HREV.0000011393.40674.13
    - "Antioxidant actions of nitric oxide", V.M. DARLEY-USMAR; R.P. PATEL; V.B. O'DONNELL; B.A. FREEMAN, Nitric Oxide: Biology and Pathobiology, ACADEMIC PRESS, (2000), pages 265 - 276
    - S.P. GOSS; B. KALYANARAMAN; N. HOGG, "Antioxidant effects of nitric oxide and nitric oxide donor compounds on low-density lipoprotein oxidation", METHODS ENZYMOL, (1999), vol. 301, pages 444 - 53
    - D.A. WINK; J.A. COOK; R. PACELLI; J. LIEBMANN; M.C. KRISHNA; J.B. MITCHELL, "Nitric oxide (NO) protects against cellular damage by reactive oxygen species", TOXICOL LETT, (1995), vol. 82-83, pages 221 - 6
    - B. BRÜNE; A. VON KNETHEN; K.B. SANDAU, "Nitric oxide (NO): an effector of apoptosis", CELL DEATH DIFFER, (1999), vol. 6, doi:doi:10.1038/sj.cdd.4400582, pages 969 - 75, XP009005853

DOI:   http://dx.doi.org/10.1038/sj.cdd.4400582
    - D. MOELLERING; J. MCANDREW; R.P. PATEL; T. CORNWELL; T. LINCOLN; X. CAO; J.L. MESSINA; H.J. FORMAN; H. JO; V.M. DARLEY-USMAR, "Nitric oxide-dependent induction of glutathione synthesis through increased expression of gamma-glutamylcysteine synthetase", ARCH BIOCHEM BIOPHYS, (1998), vol. 358, pages 74 - 82
    - U. FORSTERMANN; M. NAKANE; W.R. TRACEY; J.S. POLLOCK, "Isoforms of nitric oxide synthase: functions in the cardiovascular system", EUR HEART J, (1993), vol. 14, pages 10 - 5
    - P. HE; M. ZENG; F.E. CURRY, "Effect of nitric oxide synthase inhibitors on basal microvessel permeability and endothelial cell [Ca2+]i", AM J PHYSIOL, (1997), vol. 273, pages H747 - 55
    - M. TOBOREK; S. KAISER, "Endothelial cell functions. Relationship to atherogenesis", BASIC RES CARDIOL, (1999), vol. 94, pages 295 - 314
    - M. KELM; B. STRAUER, "Endotheliale Dysfunktion", THERAPEUTISCHE UND PROGNOSTISCHE RELEVANZ. INTERNIST., (1999), vol. 40, pages 1300 - 1307
    - T.P. AMADEU; A.B. SEABRA; M.G. DE OLIVEIRA; A.M. COSTA, "S-nitrosoglutathionecontaining hydrogel accelerates rat cutaneous wound repair", J EUR ACAD DERMATOL VENEREOL, (2007), vol. 21, pages 629 - 37
    - R. WELLER; M.J. FINNEN, "The effects of topical treatment with acidified nitrite on wound healing in normal and diabetic mice", NITRIC OXIDE, (2006), vol. 15, doi:doi:10.1016/j.niox.2006.04.002, pages 395 - 9, XP024919022

DOI:   http://dx.doi.org/10.1016/j.niox.2006.04.002
    - A.B. SHEKHTER; V.A. SEREZHENKOV; T.G. RUDENKO; A.V. PEKSHEV; A.F. VANIN, "Beneficial effect of gaseous nitric oxide on the healing of skin wounds", NITRIC OXIDE, (2005), vol. 12, doi:doi:10.1016/j.niox.2005.03.004, pages 210 - 9, XP004903036

DOI:   http://dx.doi.org/10.1016/j.niox.2005.03.004
    - W.S. MCDONALD; T.P. LO, JR.; M. THURMOND; C. JONES; R. COHEN; A. MILLER; D. BEASLEY, "Role of nitric oxide in skin flap delay", PLAST RECONSTR SURG, (2004), vol. 113, pages 927 - 31
    - C. BEIGE; P.B. MASSION; M. PELAT; J.L. BALLIGAND, "Nitric oxide and the heart: update on new paradigms", ANN N Y ACAD SEI, (2005), vol. 1047, pages 173 - 82
    - B. GASTON, "Summary: systemic effects of inhaled nitric oxide", PROC AM THORAC SOC, (2006), vol. 3, pages 170 - 2
    - T.M. DAWSON; S.H. SNYDER, "Gases as biological messengers: nitric oxide and carbon monoxide in the brain", J NEUROSCI, (1994), vol. 14, pages 5147 - 59
    - C.C. MILLER; M.K. MILLER; A. GHAFFARI; B. KUNIMOTO, "Treatment of chronic nonhealing leg ulceration with gaseous nitric oxide: a case study", J CUTAN MED SURG, (2004), vol. 8, doi:doi:10.1007/s10227-004-0106-8, pages 233 - 8, XP002568914

DOI:   http://dx.doi.org/10.1007/s10227-004-0106-8
    - A. GHAFFARI; D.H. NEIL; A. ARDAKANI; J. ROAD; A. GHAHARY; C.C. MILLER, "A direct nitric oxide gas delivery system for bacterial and mammalian cell cultures", NITRIC OXIDE, (2005), vol. 12, doi:doi:10.1016/j.niox.2005.01.006, pages 129 - 40, XP004807515

DOI:   http://dx.doi.org/10.1016/j.niox.2005.01.006
    - A. GHAFFARI; C.C. MILLER; B. MCMULLIN; A. GHAHARY, "Potential application of gaseous nitric oxide as a topical antimicrobial agent", NITRIC OXIDE, (2006), vol. 14, doi:doi:10.1016/j.niox.2005.08.003, pages 21 - 9, XP024918977

DOI:   http://dx.doi.org/10.1016/j.niox.2005.08.003
    - A. GHAFFARI; R. JALILI; M. GHAFFARI; C. MILLER; A. GHAHARY, "Efficacy of gaseous nitric oxide in the treatment of skin and soft tissue infections", WOUND REPAIR REGEN, (2007), vol. 15, pages 368 - 77
    - Z.S. GALIS; J.J. KHATRI, "Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly", CIRC RES, (2002), vol. 90, pages 251 - 62
    - S.C. TYAGI; M.R. HAYDEN, "Role of nitric oxide in matrix remodeling in diabetes and heart failure", HEART FAIL REV, (2003), vol. 8, pages 23 - 8
    - J. PFEILSCHIFTER; W. EBERHARDT; K.F. BECK, "Regulation of gene expression by nitric oxide", PFLUGERS ARCH, (2001), vol. 442, doi:doi:10.1007/s004240100586, pages 479 - 86, XP001145554

DOI:   http://dx.doi.org/10.1007/s004240100586
    - R. ZAMORA; Y. VODOVOTZ; K.S. AULAK; P.K. KIM; J.M. KANE; L. ALARCON; D.J. STUEHR; T.R. BILLIAR, "A DNA microarray study of nitric oxide-induced genes in mouse hepatocytes: implications for hepatic heme oxygenase-1 expression in ischemia/reperfusion", NITRIC OXIDE, (2002), vol. 7, pages 165 - 86
    - J. HEMISH; N. NAKAYA; V. MITTAL; G. ENIKOLOPOV, "Nitric oxide activates diverse signaling pathways to regulate gene expression", J BIOL CHEM, (2003), vol. 278, pages 42321 - 9
    - M. ZICHE; L. MORBIDELLI; E. MASINI; S. AMERINI; H.J. GRANGER; C.A. MAGGI; P. GEPPETTI; F. LEDDA, "Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P", J CLIN INVEST, (1994), vol. 94, doi:doi:10.1172/JCI117557, pages 2036 - 44, XP002455988

DOI:   http://dx.doi.org/10.1172/JCI117557
    - S.J. LEIBOVICH; P.J. POLVERINI; T.W. FONG; L.A. HARLOW; A.E. KOCH, "Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthasedependent effector mechanism", PROC NATL ACAD SCI U S A, (1994), vol. 91, pages 4190 - 4
    - N.S. BRYAN; B.O. FERNANDEZ; S.M. BAUER; M.F. GARCIA-SAURA; A.B. MILSOM; T. RASSAF; R.E. MALONEY; A. BHARTI; J. RODRIGUEZ; M. FEELI, "Nitrite is a signaling molecule and regulator of gene expression in mammalian tissues", NATURE CHEMICAL BIOLOGY, (2005), vol. 1, pages 290 - 297
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.